BlackRock, Inc. 13D and 13G filings for Mirum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 11:44 am Purchase |
2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
BLACKROCK INC BLK |
3,406,072 7.100% |
37,915 (+1.13%) |
Filing |
| 2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
BLACKROCK INC BLK |
3,368,157 7.100% |
835,515 (+32.99%) |
Filing |
| 2024-01-31 2:08 pm Purchase |
2023-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
BLACKROCK INC BLK |
2,532,642 5.400% |
854,735 (+50.94%) |
Filing |
| 2023-03-08 2:15 pm Sale |
2023-02-28 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
BLACKROCK INC BLK |
1,677,907 4.600% |
-458,770 (-21.47%) |
Filing |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
BLACKROCK INC BLK |
2,136,677 5.800% |
2,136,677 (New Position) |
Filing |